Eli Lilly on Thursday expanded its direct-to-consumer online platform LillyDirect to include telehealth providers to diagnose ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.That’s ...

In the first arrangement of its kind, Eli Lilly to connect patients through telemedicine to providers of Alzheimer’s drugs.

The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

NEW YORK (Reuters) -The biotechnology company Cassava Sciences failed on Wednesday to end a malicious prosecution lawsuit by ...

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

PathChat, a new AI model for pathology made by Modella AI, received breakthrough status in January. The device can digest ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

"They didn't value me as much," the actress says of initially not having the same name recognition as her male co-star The ...

Cassava Sciences said on Tuesday its Alzheimer's drug simufilam, which has been at the center of regulatory scrutiny, failed ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.